Publiserte artikler

Oppdatert 4.september 2017

 

  1. Anderson, K. S., G. Wallstrom, H. Langseth, M. Posner, J. N. Cheng, R. Alam, D. Chowell, I. E. Furre and J. Mork (2017). "Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer." Oral Oncology 73: 132-137.
    DOI

  2. Andreas Keller, Rounge T,  Backes C, Ludwig N,  Gislefoss R, Leidinger P, Langseth H, Meese E. "Sources to variability in circulating human miRNA signatures". RNA Biol. 2017 Aug 18:0. [Epub ahead of print] 
    DOI

  3. Schwartz, G. G., S. Tretli, L. Vos and T. E. Robsahm (2017). "Prediagnostic serum calcium and albumin and ovarian cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort." Cancer Epidemiol 49: 225-230. 
    DOI

  4. Stenehjem JS, Grimsrud TK, Rees JR, Vos L, Babigumira R, Veierød MB, Robsahm TE. "A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival". BMJ Open. 2017 Jun 21;7(6):e014829

    DOI

  5. Schwartzbaum, J., Wang M, Root E, Pietrzak M, Rempala G.A, Huang R.P, Johannesen T.B and Grimsrud T. K. (2017). "A nested case-control study of 277 prediagnostic serum cytokines and glioma." PLoS One 12(6): e0178705.

    DOI

  6. Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth, H "Cohort Profile Update: The Janus Serum Bank Cohort in Norway". International Journal of Epidemiology, 2017, 1–8. Advance Access published January 12, 2017.

    DOI

  7. Gislefoss RE, Lauritzen M, Langseth HMørkrid L."Effect of multiple freeze-thaw cycles on selected biochemical serum components". Clin Chem Lab Med. 2016 Dec 17 [Epub ahead of print]
    DOI

  8. Malhotra, J. Waterboer, T. Pawlita, M. Michel, A. Cai, Q. Zheng, W. Gao, Y. T. Lan, Q. Rothman, N. Langseth, H.Grimsrud, T. K. Yuan, J. M. Koh, W. P. Wang, R. Arslan, A. A. Zeleniuch-Jacquotte, A. Boffetta, P. Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers. Br J Cancer 2016. Epub sept.15. 

    DOI 

  9. Price AJ, Travis, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O,Stattin P, Tell GS, Trichopoulou A, Tumino R, Ueland PM, Ulvik A, de Vogel S, Vollset SE, Weinstein SJ, Key TJ, Allen NE. Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts 
    Including 6875 Cases and 8104 Controls. Eur Urol. 2016 Apr 6.
    DOI

  10. Bjorkblom B, Wibom C, Jonsson P, Moren, L, Andersson U, Borge Johannesen T, Langseth H, Antti H, Melin B. Metabolomic screening of pre-diagnostic serum samples identifies association between  α- and γ-tocopherols and glioblastoma risk. Oncotarget. 2016
    DOI 

  11. Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G. Cohort Profile: The Janus Serum Bank Cohort in Norway. Int J Epidemiol. 2016. Epub. Apr 10. 
    DOI
  12. Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J. Cutaneous Human Papillomaviruses and squamous cell carcinoma of the skin: Nested case-control study. Cancer Epidemiol Biomarkers Prev. 2016. Epub. Feb 9. 
    DOI
  13. Meyer HE, Støer NC, Samuelsen SO, Blomhoff R, Robsahm TE, Brustad M, Giovannucci EL, Bjørge T. Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men. PLoS One. 2016. Epub. March 17.
    DOI
  14. Spath F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Bjorkblom B, Wibom C, Melin B. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumour Biol. 2016. Epub. Feb 23.
    DOI
  15. Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J. Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer. Acta Oncol. 2016:1-7. Epub. Feb 15.
    DOI
  16. Satagopan JM, Sen A, Zhou Q, Lan Q, Rothman N, Langseth H, Engel LS. Bayes and empirical bayes methods for reduced rank regression models in matched case-control studies. Biometrics. 2015. Epub. Nov 17.
    DOI
  17. Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, Goodman PJ, Gunter MJ, Hamdy FC, Heliovaara M, Helzlsouer KJ, Henderson BE, Hercberg S, Hoffman-Bolton J, Hoover RN, Johansson M, Khaw KT, King IB, Knekt P, Kolonel LN, Le Marchand L, Mannisto S, Martin RM, Meyer HE, Mondul AM, Moy KA, Neal DE, Neuhouser ML, Palli D, Platz EA, Pouchieu C, Rissanen H, Schenk JM, Severi G, Stampfer MJ, Tjonneland A, Touvier M, Trichopoulou A, Weinstein SJ, Ziegler RG, Zhou CK, Allen NE. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015;102(5):1142-57.
    DOI
  18. Arem H, Brinton LA, Moore SC, Gapstur SM, Habel LA, Johnson K, Kolonel LN, McCormack VA, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Weiderpass E, Cook MB, Matthews CE. Physical Activity and Risk of Male Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2015. Epub.
    DOI
  19. Schwartzbaum J, Seweryn M, Holloman C, Harris R, Handelman SK, Rempala GA, Huang RP, Burkholder B, Brandemihl A, Kallberg H, Johannesen TB, Ahlbom A, Feychting M, Grimsrud TK. Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma. PLoS One. 2015;10(9):e0137503. Epub.
    DOI
  20. Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L. HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank. Int J Gynecol Cancer. Publish Ahead of Print. Epub.
    DOI
  21. Zigmont V, Garrett A, Peng J, Seweryn M, Rempala GA, Harris R, Holloman C, Gundersen TE, Ahlbom A, Feychting M, Johannesen TB, Grimsrud TK, Schwartzbaum J. Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma. Nutr Cancer. 2015:1-11. Epub. Aug 28.
    DOI
  22. Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE. microRNA biomarker discovery and high-throughput DNA sequencing are possible using long-term archived serum samples. Cancer Epidemiol Biomarkers Prev. 2015. Epub. Jun 24.
    DOI
  23. Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015. Epub. May 11.
    DOI
  24. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum hormones and lipids after long-term storage in the Janus Serum Bank. Clin Biochem. 2014 Dec 15.Epub.
    DOI
  25. Koutros S, Langseth H, Grimsrud TK, Barr DB, Vermeulen R, Portengen L, Wacholder S, Beane Freeman LE, Blair A, Hayes RB, Rothmann N, Engel LS. Prediagnostic Serum Organochlorine Concentrations and Metastatic Prostate Cancer: A Nested Case-Control Study in the Norwegian Janus Serum Bank Cohort. Environ Health Perspect. 2015 Mar 3.Epub.
    DOI
  26. Wibom C, Spath F, Dahlin AM, Langseth H, Hovig E, Rajaraman P, Borge Johannesen T, Andersson U, Melin B. Investigation of established genetic risk variants for glioma in pre-diagnostic samples from a population based nested case control study. Cancer Epidemiol Biomarkers Prev. 2015 Feb 20.Epub.
    DOI
  27. Støer NC, Meyer HE, Samuelsen SO.
    Reuse of controls in nested case-control studies.
    Epidemiology. 2014 Mar;25(2):315-7. doi: 10.1097
    PMID:24487222[PubMed - in process]
    http://www.ncbi.nlm.nih.gov/pubmed/24487222
  28. Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Petridou ET, Pike MC, Riboli E, Sesso HD, Snyder K, Swerdlow AJ; The European Rare Cancer Study Group, Trichopoulos D, Ursin G, van den Brandt PA, Van Den Eeden SK, Weiderpass E, Willett WC, Ewertz M, Thomas DB.
    Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results.
    J Natl Cancer Inst. 2014 Feb 19.
    http://www.ncbi.nlm.nih.gov/pubmed/24552677
  29. Faust H, Andersson K, Ekström J, Hortlund M, Robsahm TE, Dillner J.
    Prospective study of merkel cell polyomavirus and risk of merkel cell carcinoma.
    Int J Cancer. 2013 Aug 7. doi: 10.1002/ijc.28419.
    http://www.ncbi.nlm.nih.gov/pubmed/23922031
  30. de Vogel S, Ulvik A, Meyer K, Ueland PM, Nygård O, Vollset SE, Tell GS, Gregory JF 3rd, Tretli S, Bjørge T.
    Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer - a large nested case-control study within the JANUS cohort in Norway.
    Int J Cancer. 2013 Jun 25. doi: 10.1002/ijc.28347.
    http://www.ncbi.nlm.nih.gov/pubmed/23797698
  31. Anderson K, Luostarinen T, Strand AS, Langseth H, Gislefoss R, Forslund O, Pawlita M, Waterboer T,  Dillner J.
    Prospective study of genital human papillomaviruses and non-melanoma skin cancer.
    Int J Cancer. 2013 Apr 1. doi: 10.1002/ijc.28188.
    http://www.ncbi.nlm.nih.gov/pubmed/23553409
  32. de Vogel S, Meyer K, Fredriksen Å, Ulvik A, Ueland PM, Nygård O, Vollset SE, Tell GS, Tretli S, Bjørge T
    Serum folate and vitamin B12 concentrations in relation to prostate cancer risk.
    Int J Epidemiol. 2013 Feb;42(1):201-210.
    http://www.ncbi.nlm.nih.gov/pubmed/23508410
  33. Meyer HE, Robsahm TE, Bjørge T, Brustad M, Blomhoff R.
    Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies.
    Am J Clin Nutr. 2013 Jan;97(1):147-54.
    http://www.ncbi.nlm.nih.gov/pubmed/23193007
  34. Gislefoss RE, Grimsrud TK, Høie K, Mørkrid L.
    Stability of testosterone measured in male archival serum samples by two different methods.
    Scand J Clin Lab Invest. 2012 Aug 30.
    http://www.ncbi.nlm.nih.gov/pubmed/22935045
  35. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK.
    Association Between Prediagnostic IgE Levels and Risk of Glioma.
    J Natl Cancer Inst. 2012 Aug 1.
    http://www.ncbi.nlm.nih.gov/pubmed/22855780
  36. Hilde Langseth, Randi Gislefoss, Jan Ivar Martinsen and Steinar Tretli
    Scientific scope of integrating research activities in the Janus Serum Bank and Cancer Registry of Norway
    Norsk Epidemiologi 2012; 21 (2): 185-190 185
    http://www.ntnu.no/ojs/index.php/norepid/article/view/1492/1337
  37. Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J.
    Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer.
    Am J Epidemiol. 2012 Mar 14.
    http://www.ncbi.nlm.nih.gov/pubmed/22419740
  38. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, Morkrid L, Gislefoss R, Ueland PM. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012; 58(2):402-410.
    http://www.ncbi.nlm.nih.gov/pubmed/22194632?dopt=Citation
  39. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012; 23(2):363-370.
    http://www.ncbi.nlm.nih.gov/pubmed/22193397?dopt=Citation
  40. Dahlstrom LA, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, Wiklund F, Skare GB, Eklund C, Sjolin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J. Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer. Cancer Epidemiol Biomarkers Prev 2011; 20(12):2541-2550.
    http://www.ncbi.nlm.nih.gov/pubmed/21994401?dopt=Citation
  41. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011; 8(3):506-516.
    http://www.ncbi.nlm.nih.gov/pubmed/21558792?dopt=Citation
  42. Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schuz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, Yoo KY, Zahm SH, Straif K, Blair A. AGRICOH: a consortium of agricultural cohorts. Int J Environ Res Public Health 2011; 8(5):1341-1357.
    http://www.ncbi.nlm.nih.gov/pubmed/21655123?dopt=Citation
  43. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 2010; 102(11):1665-1669.
    http://www.ncbi.nlm.nih.gov/pubmed/20407437?dopt=Citation
  44. Key TJ, Appleby PN, Reeves GK, Roddam AW.
    Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
    Lancet Oncol. 2010 Jun;11(6):530-42.
    http://www.ncbi.nlm.nih.gov/pubmed/20472501
  45. Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Morkrid L, Ueland PM. Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years. J Nutr 2010; 140(3):522-526.
    http://www.ncbi.nlm.nih.gov/pubmed/20071651?dopt=Citation
  46. Langseth H, Luostarinen T, Bray F, Dillner J. Ensuring quality in studies linking cancer registries and biobanks. Acta Oncol 2010; 49(3):368-377.
    http://www.ncbi.nlm.nih.gov/pubmed/20059313?dopt=Citation
  47. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009; 47(5):596-603.
    http://www.ncbi.nlm.nih.gov/pubmed/19290843?dopt=Citation
  48. Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Love A, Mahlamaki E, Thoresen S, Tryggvadottir L, Wadell G, Youngman L, Lehtinen M. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009; 169(4):480-488.
    http://www.ncbi.nlm.nih.gov/pubmed/19074773?dopt=Citation
  49. Langseth H, Gislefoss R, Martinsen JI, Stornes A, Lauritzen M, Andersen A, Jellum E, Dillner J. The Janus Serum Bank: From sample collection to cancer research. Cancer in Norway 2009.
    http://www.kreftregisteret.no/Global/29-01-2010%20CIN_ 2008_Special_Issue_Janus_Web.pdf
  50. Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA. Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ Health Perspect 2009; 117(10):1514-1519.
    http://www.ncbi.nlm.nih.gov/pubmed/20019899?dopt=Citation
  51. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009; 100(3):450-454.
    http://www.ncbi.nlm.nih.gov/pubmed/19156140?dopt=Citation
  52. Gislefoss RE, Grimsrud TK, Morkrid L. Long-term stability of serum components in the Janus Serum Bank. Scand J Clin Lab Invest 2008; 68(5):402-409.
    http://www.ncbi.nlm.nih.gov/pubmed/18752145?dopt=Citation
  53. Jorgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008; 67(6):860-866.
    http://www.ncbi.nlm.nih.gov/pubmed/17644543?dopt=Citation
  54. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100(3):170-183.
    http://www.ncbi.nlm.nih.gov/pubmed/18230794?dopt=Citation
  55. Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Lung Cancer 2008; 61(2):235-243.
    http://www.ncbi.nlm.nih.gov/pubmed/18281122?dopt=Citation
  56. Vatten LJ, Holly JM, Gunnell D, Tretli S. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Cancer Epidemiol Biomarkers Prev 2008; 17(8):2097-2100.
    http://www.ncbi.nlm.nih.gov/pubmed/18708402?dopt=Citation
  57. Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res 2007; 67(11):5545-5552.
    http://www.ncbi.nlm.nih.gov/pubmed/17545638?dopt=Citation
  58. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007; 56(7):918-925.
    http://www.ncbi.nlm.nih.gov/pubmed/17317788?dopt=Citation
  59. Kjaerheim K, Roe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson E, Andersen A, Boffetta P, Pawlita M. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 2007; 120(11):2459-2465.
    http://www.ncbi.nlm.nih.gov/pubmed/17315193?dopt=Citation
  60. Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J. No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus. Int J Cancer 2007; 121(5):1098-1102.
    http://www.ncbi.nlm.nih.gov/pubmed/17471560?dopt=Citation
  61. Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyronen PP, Lenner P, Luostarinen T, Love A, Ogmundsdottir H, Stattin P, Tenkanen L, Tryggvadottir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 2007; 46(3):286-307.
    http://www.ncbi.nlm.nih.gov/pubmed/17450464?dopt=Citation
  62. Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(6):1184-1188.
    http://www.ncbi.nlm.nih.gov/pubmed/16775179?dopt=Citation
  63. Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P.
    Serum adiponectin is not associated with risk of colorectal cancer.
    Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):401-2.
    http://cebp.aacrjournals.org/content/15/2/401.long
  64. Gislefoss R, Jellum E. The Janus serum bank and biomarkers of cancer. Norsk Epidemiologi 2006; 16(1):53-57.
    http://www.ntnu.no/ojs/index.php/norepid/article/view/206
  65. Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M. Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2005; 14(2):385-389.
    http://www.ncbi.nlm.nih.gov/pubmed/15734962?dopt=Citation
  66. Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14(12):2952-2955.
    http://www.ncbi.nlm.nih.gov/pubmed/16365015?dopt=Citation
  67. Tedeschi R, Luostarinen T, De PP, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J. Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk. Br J Cancer 2005; 93(7):834-837.
    http://www.ncbi.nlm.nih.gov/pubmed/16136049?dopt=Citation
  68. Bjorge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Trope CG, Dorum A. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer 2004; 91(10):1829-1834.
    http://www.ncbi.nlm.nih.gov/pubmed/15477862?dopt=Citation
  69. Chiba H, Tretli S, Lund E, Wakai K, Takezaki T, Senoo H, Sonoda S, Tajima K. Lack of HTLV-I carriers in the Sami, an ethnic group living in the Arctic area in Norway. Asian Pac J Cancer Prev 2004; 5(1):50-53.
    http://www.ncbi.nlm.nih.gov/pubmed/15075005
  70. Ekstrom PO, Bjorge T, Dorum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E. Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis. Anal Chem 2004; 76(15):4406-4409.
    http://www.ncbi.nlm.nih.gov/pubmed/15283579?dopt=Citation
  71. Luostarinen T, Lehtinen M, Bjorge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer 2004; 40(7):1058-1065.
    http://www.ncbi.nlm.nih.gov/pubmed/15093583?dopt=Citation
  72. Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004; 108(3):418-424.
    http://www.ncbi.nlm.nih.gov/pubmed/14648709?dopt=Citation
  73. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109(1):149-152.
    http://www.ncbi.nlm.nih.gov/pubmed/14735482?dopt=Citation
  74. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108(1):104-108.
    http://www.ncbi.nlm.nih.gov/pubmed/14618623?dopt=Citation
  75. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13(12):2175-2180.
    http://www.ncbi.nlm.nih.gov/pubmed/15598777?dopt=Citation
  76. Jellum E, Gislefoss RE. Serumbanken "Janus" i kreftforskning: Fra håndverk til høy teknologi. Klinisk kjemi (Rikshospitalet) 2003;403-15.
  77. Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen S, Dillner J. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 2003; 188(1):49-55.
    http://www.ncbi.nlm.nih.gov/pubmed/12548195?dopt=Citation
  78. Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol 2003; 189(5):1287-1292.
    http://www.ncbi.nlm.nih.gov/pubmed/14634555?dopt=Citation
  79. Stattin P, Kaaks R, Johansson R, Gislefoss R, Soderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T. Plasma leptin is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12(5):474-475.
    http://www.ncbi.nlm.nih.gov/pubmed/12750247?dopt=Citation
  80. Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SO, Dillner J. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87(1):61-64.
    http://www.ncbi.nlm.nih.gov/pubmed/12085257?dopt=Citation
  81. Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. Am J Epidemiol 2002; 156(8):687-692.
    http://www.ncbi.nlm.nih.gov/pubmed/12370156?dopt=Citation
  82. Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinen M, Dillner J. Humant papillomavirus-infeksjon som risikofaktor for plateepitel-karsinom. Tidsskr Nor Laegeforen 2002; 122(16):1544-8.
    http://tidsskriftet.no/article/560600
  83. Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, Thoresen S, Abeler V. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. Br J Cancer 2002; 87(2):175-180.
    http://www.ncbi.nlm.nih.gov/pubmed/12107839?dopt=Citation
  84. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 2002; 99(1):124-129.
    http://www.ncbi.nlm.nih.gov/pubmed/11948503?dopt=Citation
  85. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 285(1):47-51.
    http://www.ncbi.nlm.nih.gov/pubmed/11150108?dopt=Citation
  86. Hostmark AT, Glattre E, Jellum E. Effect of long-term storage on the concentration of albumin and free fatty acids in human sera. Scand J Clin Lab Invest 2001; 61(6):443-447.
    http://www.ncbi.nlm.nih.gov/pubmed/11681533?dopt=Citation
  87. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344(15):1125-1131.
    http://www.ncbi.nlm.nih.gov/pubmed/11297703?dopt=Citation
  88. Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, Thoresen S, Youngman L, Hakulinen T. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control 2000; 11(9):783-790.
    http://www.ncbi.nlm.nih.gov/pubmed/11075866?dopt=Citation
  89. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000; 85(1):35-39.
    http://www.ncbi.nlm.nih.gov/pubmed/10585579?dopt=Citation
  90. Ward EM, Schulte P, Grajewski B, Andersen A, Patterson DG, Jr., Turner W, Jellum E, Deddens JA, Friedland J, Roeleveld N, Waters M, Butler MA, DiPietro E, Needham LL. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomarkers Prev 2000; 9(12):1357-1367.
    http://www.ncbi.nlm.nih.gov/pubmed/11142422?dopt=Citation
  91. Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A, Ekbom A. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 1999; 82(1):1-5.
    http://www.ncbi.nlm.nih.gov/pubmed/10360811?dopt=Citation
  92. Berg JP, Engeland A, Jellum E, Glattre E. Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case control study. Thyroid 1999; 9(3):285-288.
    http://www.ncbi.nlm.nih.gov/pubmed/10211606?dopt=Citation
  93. Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999; 34(4):353-360.
    http://www.ncbi.nlm.nih.gov/pubmed/10365894?dopt=Citation
  94. Luostarinen T, af G, V, Bjorge T, Eklund C, Hakama M, Hakulinen T, Jellum E, Koskela P, Paavonen J, Pukkala E, Schiller JT, Thoresen S, Youngman LD, Dillner J, Lehtinen M. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer 1999; 80(6):818-822.
    http://www.ncbi.nlm.nih.gov/pubmed/10074912?dopt=Citation
  95. Bjorge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57(18):3989-3992.
    http://www.ncbi.nlm.nih.gov/pubmed/9307283?dopt=Citation
  96. Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315(7109):646-649.
    http://www.ncbi.nlm.nih.gov/pubmed/9310566?dopt=Citation
  97. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997; 89(17):1293-1299.
    http://www.ncbi.nlm.nih.gov/pubmed/9293920?dopt=Citation
  98. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 1997; 71(4):545-551.
    http://www.ncbi.nlm.nih.gov/pubmed/9178806?dopt=Citation
  99. Jellum E, Dollekamp H, Brunsvig A, Gislefoss R. Diagnostic applications of chromatography and capillary electrophoresis. J Chromatogr B Biomed Sci Appl 1997; 689(1):155-164.
    http://www.ncbi.nlm.nih.gov/pubmed/9061490?dopt=Citation
  100. Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev 1997; 6(11):967-969.
    http://www.ncbi.nlm.nih.gov/pubmed/9367072?dopt=Citation
  101. Witherell HL, Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J. Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. J Infect Dis 1997; 176(6):1641-1644.
    http://www.ncbi.nlm.nih.gov/pubmed/9395383?dopt=Citation
  102. Jellum E, Dollekamp H, Blessum C. Capillary electrophoresis for clinical problem solving: analysis of urinary diagnostic metabolites and serum proteins. J Chromatogr B Biomed Appl 1996; 683(1):55-65.
    http://www.ncbi.nlm.nih.gov/pubmed/8876439?dopt=Citation
  103. Jellum E, Andersen A, Baklien K, Dalen A, Iversen OE, Lund-Larsen P, Theodorsen L, Orjasaeter H. The use of the Janus serum bank in studies related to the environment and cancer. Norwegian Acad Sci Letters 1996;23-32.
  104. Jellum E, Andersen A, Baklien K, Dalen A, Iversen OE, Lund-Larsen P, Theodorsen L, Orjasaeter H, Brunsvig A, Gislefoss R. Use of the Janus serum bank in cancer research. NORD Biotech 1996; 9:43-52.
  105. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 1995; 103 Suppl 3:85-88.
    http://www.ncbi.nlm.nih.gov/pubmed/7635118?dopt=Citation
  106. Berg JP, Glattre E, Haldorsen T, Hostmark AT, Bay IG, Johansen AF, Jellum E. Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway. Cancer Causes Control 1994; 5(5):433-439.
    http://www.ncbi.nlm.nih.gov/pubmed/7999965?dopt=Citation
  107. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330(18):1267-1271.
    http://www.ncbi.nlm.nih.gov/pubmed/8145781?dopt=Citation
  108. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. The JANUS serum bank. Sci Total Environ 1993; 139-140:527-535.
    http://www.ncbi.nlm.nih.gov/pubmed/8272856?dopt=Citation
  109. Paus E, Theodorsen L, Engeland A. Prostate-specific antigen in serum from blood donors with subsequent prostate cancer diagnosis. Eur J Cancer 1993; 29A(8):1221-1222.
    http://www.ncbi.nlm.nih.gov/pubmed/7686023?dopt=Citation
  110. Vatten LJ, Bjerve KS, Andersen A, Jellum E. Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway. Eur J Cancer 1993; 29A(4):532-538.
    http://www.ncbi.nlm.nih.gov/pubmed/8435206?dopt=Citation
  111. Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes Control 1991; 2(2):125-131.
    http://www.ncbi.nlm.nih.gov/pubmed/1651778?dopt=Citation
  112. Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 1991; 49(3):387-393.
    http://www.ncbi.nlm.nih.gov/pubmed/1655660?dopt=Citation
  113. Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 1989; 18(1):45-49.
    http://www.ncbi.nlm.nih.gov/pubmed/2722382?dopt=Citation
  114. Jellum E, Thorsrud AK. Profiling cells and body fluids--chromatography and two-dimensional electrophoresis as complementary techniques. J Chromatogr 1989; 488(1):105-127.
    http://www.ncbi.nlm.nih.gov/pubmed/2715280?dopt=Citation
  115. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320(11):689-695.
    http://www.ncbi.nlm.nih.gov/pubmed/2537928?dopt=Citation
  116. Thoresen SO, Myking O, Glattre E, Rootwelt K, Andersen A, Foss OP. Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer. Br J Cancer 1988; 57(1):105-108.
    http://www.ncbi.nlm.nih.gov/pubmed/3348941?dopt=Citation
  117. Zurawski VR, Jr., Orjaseter H, Andersen A, Jellum E. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer 1988; 42(5):677-680.
    http://www.ncbi.nlm.nih.gov/pubmed/3182103?dopt=Citation
  118. Jellum E, Andersen A, Orjasaeter H, Foss OP, Theodorsen L, Lund-Larsen P. The JANUS serum bank and early detection of cancer. Biochim Clinica 1987; 11:191-195.
  119. Kotlar HK, Sanner T, Eker P, Pihl A, Orjasaeter H, Harvei S, Theodorsen L, Jellum E. Immune anti-tumor response in the preclinical period of lung cancer. Eur J Cancer Clin Oncol 1982; 18(3):317-319.
    http://www.ncbi.nlm.nih.gov/pubmed/7201399?dopt=Citation
  120. Orjasaeter H. The "Janus" serum research programme: a multipurpose project for retrospective as well as prospective investigations of cancer. Acta Pathol Microbiol Scand Suppl 1974; Suppl 248:175-179.
    http://www.ncbi.nlm.nih.gov/pubmed/4451120?dopt=Citation